APA (7th ed.) Citation

Badenetti, L., Manzoli, R., Trevisan, M., D’Avanzo, F., Tomanin, R., & Moro, E. (2023). A novel CRISPR/Cas9-based iduronate-2-sulfatase (IDS) knockout human neuronal cell line reveals earliest pathological changes. Scientific Reports, 13(1), . https://doi.org/10.1038/s41598-023-37138-5

Chicago Style (17th ed.) Citation

Badenetti, Lorenzo, Rosa Manzoli, Marta Trevisan, Francesca D’Avanzo, Rosella Tomanin, and Enrico Moro. "A Novel CRISPR/Cas9-based Iduronate-2-sulfatase (IDS) Knockout Human Neuronal Cell Line Reveals Earliest Pathological Changes." Scientific Reports 13, no. 1 (2023). https://doi.org/10.1038/s41598-023-37138-5.

MLA (9th ed.) Citation

Badenetti, Lorenzo, et al. "A Novel CRISPR/Cas9-based Iduronate-2-sulfatase (IDS) Knockout Human Neuronal Cell Line Reveals Earliest Pathological Changes." Scientific Reports, vol. 13, no. 1, 2023, https://doi.org/10.1038/s41598-023-37138-5.